Return to Home [X]

Exciting News: Introducing the New Essential Evidence Plus!

We are thrilled to announce that a brand-new version of Essential Evidence Plus is on its way! Mark your calendars for the launch date, September 11th, as we are introducing a modern, mobile-first application that will revolutionize your experience. With this update, accessing our valuable content will be easier and more convenient than ever before.

What to Expect from the New Essential Evidence Plus:

  1. Modern Mobile-First Experience: Our new application has been meticulously designed with a mobile-first approach. No matter what device you're using, whether it's a smartphone, tablet, or desktop, you'll enjoy a seamless and intuitive user experience.
  2. Enhanced Accessibility: We understand the importance of accessing content from anywhere, at any time. The new Essential Evidence Plus will provide you with the flexibility to explore our extensive collection of evidence-based resources on the go, making it easier to stay up to date with the latest medical knowledge and interactive tools.
  3. Improved User Interface: We have revamped our user interface to ensure effortless navigation and a visually appealing experience. Finding the information, you need will be quicker and more intuitive, saving you valuable time and effort.

Essential Evidence Plus will be available to users during this transition. However, please note that ability to create new trial and individual subscriptions will not be available from September 8th to September 11th 7:00 AM EST. During this period, we will be working diligently to transfer our existing system to the upgraded platform, ensuring a seamless transition for all users.

We apologize for any inconvenience caused by this temporary interruption. Rest assured, our team is committed to bringing you a superior user experience, and we appreciate your patience and understanding during this time.

Stay Tuned for the New Essential Evidence Plus!

We are counting down the days until September 11th when the new Essential Evidence Plus will be available for you to explore. Get ready to unlock a wealth of evidence-based resources that empower you in your medical decision-making process.

Thank you for your continued support, and we look forward to delivering an exceptional experience with the all-new Essential Evidence Plus!

Essential Evidence Plus

Browse Databases and Tools

Sort by Show per page
  • Doctors or mid-level providers for abortion
    Cochrane Systematic Reviews, 20-Jul-2015
  • Domestic violence screening and intervention programmes for adults with dental or facial injury
    Cochrane Systematic Reviews, 27-Oct-2015
  • Domiciliary oxygen for chronic obstructive pulmonary disease
    Cochrane Systematic Reviews, 19-Oct-2005
  • Domiciliary oxygen for interstitial lung disease
    Cochrane Systematic Reviews, 23-Jul-2001
  • Donepezil for dementia due to Alzheimer's disease
    Cochrane Systematic Reviews, 18-Jun-2018
  • Donepezil for dementia in people with Down syndrome
    Cochrane Systematic Reviews, 21-Jan-2009
  • Donepezil for mild cognitive impairment
    Cochrane Systematic Reviews, 19-Jul-2006
  • Donepezil for vascular cognitive impairment
    Cochrane Systematic Reviews, 26-Jan-2004
  • Dopamine agents for hepatic encephalopathy
    Cochrane Systematic Reviews, 6-Feb-2014
  • Dopamine agonist therapy in early Parkinson's disease
    Cochrane Systematic Reviews, 12-Nov-2008
  • Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent miscarriage history
    Cochrane Systematic Reviews, 25-Jul-2016
  • Dopamine agonists for preventing ovarian hyperstimulation syndrome
    Cochrane Systematic Reviews, 14-Apr-2021
  • Dopamine agonists for the treatment of restless legs syndrome
    Cochrane Systematic Reviews, 15-Mar-2011
  • Dopamine for prevention of morbidity and mortality in term newborn infants with suspected perinatal asphyxia
    Cochrane Systematic Reviews, 22-Jul-2002
  • Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies
    Cochrane Systematic Reviews, 30-Jan-2015
  • Dopamine versus dobutamine for hypotensive preterm infants
    Cochrane Systematic Reviews, 21-Jul-2003
  • Dopamine versus no treatment to prevent renal dysfunction in indomethacin‐treated preterm newborn infants
    Cochrane Systematic Reviews, 22-Jul-2002
  • Dornase alfa for cystic fibrosis
    Cochrane Systematic Reviews, 18-Mar-2021
  • Double bag or Y‐set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end‐stage kidney disease
    Cochrane Systematic Reviews, 13-Aug-2014
  • Double gloving to reduce surgical cross‐infection
    Cochrane Systematic Reviews, 19-Jul-2006

Login or Subscribe


Not Yet a Subscriber?

Doctor with handheld

We offer subscriptions for individuals and institutions

To find out about all the benefits of a year-long subscription to Essential Evidence Plus, click the button below!

Learn More